rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1982-9-10
|
pubmed:abstractText |
Synoviorthesis was performed in 217 joints from 111 patients suffering from different stages of rheumatoid arthritis (RA). 32P-colloidal chromic phosphate was employed, with an average dose from 6 mCi for large joints (knees) to 0.3 mCi for small peripheral joints such as average dose from 6 mCi for large joints (knees) to 0.3 mCi for small peripheral joints such as the MCP or PIP joints. Satisfactory clinical results were observed in 84% of the cases and no significant side effects resulted after a follow-up period from 1 to 10 years. Striking effects after treatment were observed through histopathological studies (light and electron microscopy) and the use of contrast arthrography. We concluded that radioactive synovectomy with 32P-chromate is a very useful method for the local treatment of RA.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0315-162X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
229-38
|
pubmed:dateRevised |
2006-4-11
|
pubmed:meshHeading |
pubmed-meshheading:7097682-Arthritis, Rheumatoid,
pubmed-meshheading:7097682-Chromium,
pubmed-meshheading:7097682-Chromium Compounds,
pubmed-meshheading:7097682-Colloids,
pubmed-meshheading:7097682-Female,
pubmed-meshheading:7097682-Humans,
pubmed-meshheading:7097682-Male,
pubmed-meshheading:7097682-Microscopy, Electron,
pubmed-meshheading:7097682-Outcome and Process Assessment (Health Care),
pubmed-meshheading:7097682-Phosphates,
pubmed-meshheading:7097682-Phosphorus Radioisotopes
|
pubmed:articleTitle |
Synoviorthesis with 32P-colloidal chromic phosphate in rheumatoid arthritis--clinical, histopathologic and arthrographic changes.
|
pubmed:publicationType |
Journal Article
|